Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study.

Lorenz DR, Uno H, Wolinsky SM, Gabuzda D.

EClinicalMedicine. 2019 Jan;7:55-64. doi: 10.1016/j.eclinm.2019.01.003. Epub 2019 Jan 24.

2.

Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.

Guha D, Mukerji SS, Chettimada S, Misra V, Lorenz DR, Morgello S, Gabuzda D.

AIDS. 2019 Mar 15;33(4):615-625. doi: 10.1097/QAD.0000000000002121.

3.

Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection.

Aldersley J, Lorenz DR, Misra V, Uno H, Gabuzda D.

AIDS. 2019 Jan 27;33(1):145-152. doi: 10.1097/QAD.0000000000002059.

4.

Low T-cell subsets prior to development of virus-associated cancer in HIV-seronegative men who have sex with men.

Dutta A, Uno H, Lorenz DR, Wolinsky SM, Gabuzda D.

Cancer Causes Control. 2018 Nov;29(11):1131-1142. doi: 10.1007/s10552-018-1090-4. Epub 2018 Oct 12.

5.

Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy.

Chettimada S, Lorenz DR, Misra V, Dillon ST, Reeves RK, Manickam C, Morgello S, Kirk GD, Mehta SH, Gabuzda D.

Sci Rep. 2018 May 8;8(1):7227. doi: 10.1038/s41598-018-25515-4.

6.

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States.

Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D, Ellis RJ, Letendre S, Gabuzda D.

Clin Infect Dis. 2018 Sep 28;67(8):1182-1190. doi: 10.1093/cid/ciy267.

7.

In vivo characterization of macrophage-tropic simian immunodeficiency virus molecular clones in rhesus macaques.

Gumber S, Amancha PK, Yen PJ, Villinger F, Gabuzda D, Byrareddy SN.

J Neurovirol. 2018 Aug;24(4):411-419. doi: 10.1007/s13365-018-0628-2. Epub 2018 Mar 28.

8.

Longitudinal Modeling of Depressive Trajectories Among HIV-Infected Men Using Cocaine.

Mukerji S, Haghighat R, Misra V, Lorenz DR, Holman A, Dutta A, Gabuzda D.

AIDS Behav. 2017 Jul;21(7):1985-1995. doi: 10.1007/s10461-017-1801-y.

9.

Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.

Dutta A, Uno H, Holman A, Lorenz DR, Gabuzda D.

Cancer Causes Control. 2017 Jul;28(7):767-777. doi: 10.1007/s10552-017-0896-9. Epub 2017 Apr 27.

10.

Marijuana Use Impacts Midlife Cardiovascular Events in HIV-Infected Men.

Lorenz DR, Dutta A, Mukerji SS, Holman A, Uno H, Gabuzda D.

Clin Infect Dis. 2017 Aug 15;65(4):626-635. doi: 10.1093/cid/cix391.

11.

Long-term nitrite inhalant exposure and cancer risk in MSM.

Dutta A, Uno H, Holman A, Lorenz DR, Wolinsky SM, Gabuzda D.

AIDS. 2017 May 15;31(8):1169-1180. doi: 10.1097/QAD.0000000000001451.

12.

Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.

Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, Koralnik IJ, Gabuzda D.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):246-255. doi: 10.1097/QAI.0000000000001362.

13.

Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era.

Solomon IH, De Girolami U, Chettimada S, Misra V, Singer EJ, Gabuzda D.

BMC Infect Dis. 2017 Feb 17;17(1):151. doi: 10.1186/s12879-017-2246-7.

14.

Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA.

Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth Joseph S, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston A, Wojna V, Wright E, Spudich S.

J Virus Erad. 2016 Oct 5;2(4):243-250.

15.

Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.

Mukerji SS, Locascio JJ, Misra V, Lorenz DR, Holman A, Dutta A, Penugonda S, Wolinsky SM, Gabuzda D.

Clin Infect Dis. 2016 Oct 15;63(8):1130-1139. doi: 10.1093/cid/ciw495. Epub 2016 Jul 22.

16.

Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.

Pery E, Sheehy A, Miranda Nebane N, Misra V, Mankowski MK, Rasmussen L, Lucile White E, Ptak RG, Gabuzda D.

Virology. 2015 Oct;484:276-87. doi: 10.1016/j.virol.2015.06.014. Epub 2015 Jul 1.

17.

Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.

Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D.

J Acquir Immune Defic Syndr. 2015 May 1;69(1):18-28. doi: 10.1097/QAI.0000000000000551.

18.
19.

Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.

Pery E, Sheehy A, Nebane NM, Brazier AJ, Misra V, Rajendran KS, Buhrlage SJ, Mankowski MK, Rasmussen L, White EL, Ptak RG, Gabuzda D.

J Biol Chem. 2015 Apr 17;290(16):10504-17. doi: 10.1074/jbc.M114.626903. Epub 2015 Feb 27.

20.

Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.

Yen PJ, Mefford ME, Hoxie JA, Williams KC, Desrosiers RC, Gabuzda D.

Virology. 2014 Jun;458-459:53-68. doi: 10.1016/j.virol.2014.03.024. Epub 2014 May 8.

21.

Astrophysics: The MAD world of black holes.

Gabuzda D.

Nature. 2014 Jun 5;510(7503):42-3. doi: 10.1038/510042a. No abstract available.

PMID:
24899300
22.

Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.

Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D.

AIDS. 2014 Jul 17;28(11):1579-91. doi: 10.1097/QAD.0000000000000303.

23.

Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.

Yen PJ, Herschhorn A, Haim H, Salas I, Gu C, Sodroski J, Gabuzda D.

J Virol. 2014 May;88(9):5014-28. doi: 10.1128/JVI.02785-13. Epub 2014 Feb 19.

24.

Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.

Cassol E, Misra V, Morgello S, Gabuzda D.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1087-97. doi: 10.1007/s11481-013-9512-2. Epub 2013 Nov 21. Review.

25.

Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.

Cassol E, Misra V, Holman A, Kamat A, Morgello S, Gabuzda D.

BMC Infect Dis. 2013 May 4;13:203. doi: 10.1186/1471-2334-13-203.

26.

Physiology: Inflammation links ageing to the brain.

Gabuzda D, Yankner BA.

Nature. 2013 May 9;497(7448):197-8. doi: 10.1038/nature12100. Epub 2013 May 1. No abstract available.

27.

Dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin mediates HIV-1 infection of and transmission by M2a-polarized macrophages in vitro.

Cassol E, Cassetta L, Rizzi C, Gabuzda D, Alfano M, Poli G.

AIDS. 2013 Mar 13;27(5):707-16. doi: 10.1097/QAD.0b013e32835cfc82.

28.

A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.

Holman AG, Gabuzda D.

PLoS One. 2012;7(11):e49538. doi: 10.1371/journal.pone.0049538. Epub 2012 Nov 14.

29.

Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancers.

Yan Z, Shah PK, Amin SB, Samur MK, Huang N, Wang X, Misra V, Ji H, Gabuzda D, Li C.

Nucleic Acids Res. 2012 Sep 1;40(17):e135. Epub 2012 May 29.

30.

Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.

Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):234-43. doi: 10.1097/QAI.0b013e318256f3bc.

31.

Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation.

Mukerji J, Olivieri KC, Misra V, Agopian KA, Gabuzda D.

Retrovirology. 2012 Jun 22;9:33. doi: 10.1186/1742-4690-9-33.

32.

A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.

Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, Li C, Morgello S, Gabuzda D.

PLoS One. 2012;7(2):e30881. doi: 10.1371/journal.pone.0030881. Epub 2012 Feb 17.

34.

Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.

Lyons JL, Uno H, Ancuta P, Kamat A, Moore DJ, Singer EJ, Morgello S, Gabuzda D.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):371-9. doi: 10.1097/QAI.0b013e3182237e54.

35.

CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.

Gray LR, Gabuzda D, Cowley D, Ellett A, Chiavaroli L, Wesselingh SL, Churchill MJ, Gorry PR.

J Neurovirol. 2011 Feb;17(1):82-91. doi: 10.1007/s13365-010-0001-6. Epub 2010 Nov 30.

36.

HIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites.

Holman AG, Mefford ME, O'Connor N, Gabuzda D.

AIDS Res Ther. 2010 Dec 14;7:43. doi: 10.1186/1742-6405-7-43.

37.

Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Kamat A, Ancuta P, Blumberg RS, Gabuzda D.

PLoS One. 2010 Nov 15;5(11):e15533. doi: 10.1371/journal.pone.0015533.

38.

Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes.

Olivieri KC, Agopian KA, Mukerji J, Gabuzda D.

AIDS Res Hum Retroviruses. 2010 Apr;26(4):495-500. doi: 10.1089/aid.2009.0257.

39.

Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Ancuta P, Liu KY, Misra V, Wacleche VS, Gosselin A, Zhou X, Gabuzda D.

BMC Genomics. 2009 Aug 27;10:403. doi: 10.1186/1471-2164-10-403.

40.
41.

Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.

Haim H, Si Z, Madani N, Wang L, Courter JR, Princiotto A, Kassa A, DeGrace M, McGee-Estrada K, Mefford M, Gabuzda D, Smith AB 3rd, Sodroski J.

PLoS Pathog. 2009 Apr;5(4):e1000360. doi: 10.1371/journal.ppat.1000360. Epub 2009 Apr 3.

42.

Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.

Gray L, Roche M, Churchill MJ, Sterjovski J, Ellett A, Poumbourios P, Sherieff S, Wang B, Saksena N, Purcell DF, Wesselingh S, Cunningham AL, Brew BJ, Gabuzda D, Gorry PR.

J Virol. 2009 Jun;83(11):5430-41. doi: 10.1128/JVI.02648-08. Epub 2009 Mar 25. Erratum in: J Virol. 2009 Aug;83(15):7794. Sheffief, Shameem [corrected to Sherieff, Shameem].

43.

Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.

Pery E, Rajendran KS, Brazier AJ, Gabuzda D.

J Virol. 2009 Mar;83(5):2374-81. doi: 10.1128/JVI.01898-08. Epub 2008 Dec 24.

44.

Evolution of the aging brain transcriptome and synaptic regulation.

Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, Wang J, Pan Y, Gabuzda DH, Li C, Prolla TA, Yankner BA.

PLoS One. 2008 Oct 2;3(10):e3329. doi: 10.1371/journal.pone.0003329.

45.

Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues.

Mefford ME, Gorry PR, Kunstman K, Wolinsky SM, Gabuzda D.

AIDS Res Hum Retroviruses. 2008 Sep;24(9):1215-20. doi: 10.1089/aid.2008.0009.

46.

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.

Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D.

PLoS One. 2008 Jun 25;3(6):e2516. doi: 10.1371/journal.pone.0002516.

47.

The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.

Wang J, Shackelford JM, Selliah N, Shivers DK, O'Neill E, Garcia JV, Muthumani K, Weiner D, Yu XF, Gabuzda D, Finkel TH.

DNA Cell Biol. 2008 May;27(5):267-77. doi: 10.1089/dna.2007.0707.

PMID:
18462066
48.

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

Sterjovski J, Churchill MJ, Ellett A, Gray LR, Roche MJ, Dunfee RL, Purcell DF, Saksena N, Wang B, Sonza S, Wesselingh SL, Karlsson I, Fenyo EM, Gabuzda D, Cunningham AL, Gorry PR.

Retrovirology. 2007 Dec 12;4:89.

49.

Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.

Mehle A, Wilson H, Zhang C, Brazier AJ, McPike M, Pery E, Gabuzda D.

J Virol. 2007 Dec;81(23):13235-41. Epub 2007 Sep 26.

50.

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, Learmont J, Sullivan JS, Roche M, Zaunders JJ, Gabuzda D, Crowe SM, Mills J, Lewin SR, Brew BJ, Cunningham AL, Churchill MJ.

Retrovirology. 2007 Sep 23;4:66.

Supplemental Content

Loading ...
Support Center